Top ▲

FZD2

Click here for help

Target not currently curated in GtoImmuPdb

Target id: 230

Nomenclature: FZD2

Family: Class Frizzled GPCRs

Gene and Protein Information Click here for help
Frizzled family G protein-coupled receptor
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human 7 565 17q21.31 FZD2 frizzled class receptor 2 19
Mouse 7 570 11 E1 Fzd2 frizzled class receptor 2 8
Rat 7 570 10q32.1 Fzd2 frizzled class receptor 2 2
Previous and Unofficial Names Click here for help
Fz2 | Frizzled-2 | Drosophila polarity gene homolog 2 | frizzled family receptor 2 | Fzd10 | Fz10
Database Links Click here for help
Alphafold
CATH/Gene3D
ChEMBL Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Gene
OMIM
Pharos
RefSeq Nucleotide
RefSeq Protein
UniProtKB
Wikipedia
Natural/Endogenous Ligands Click here for help
Wnt-5a {Sp: Human}

Download all structure-activity data for this target as a CSV file go icon to follow link

Agonist Comments
FZDs are receptors for WNT proteins. Until now FZD2 has been proven to bind to WNT 2, 3, 3A, 5A, 6, 7A and 8B. For more detail information see [3].
Antagonist Comments
UM206 is a synthetic peptidic FZD ligand whose sequence is derived from regions of high homology between the ligands Wnt3a and Wnt5a [5]. It acts as an antagonist of FZD1/2 signalling [9], and has shown efficacy in aminal models of cardiovascular disease [5,13].
Antibodies
Key to terms and symbols Click column headers to sort
Antibody Sp. Action Value Parameter Reference
vantictumab Peptide Click here for species-specific activity table Hs Antagonist ~9.0 pIC50 4
pIC50 ~9.0 (IC50 ~1.1x10-9 M) [4]
Primary Transduction Mechanisms Click here for help
Transducer Effector/Response
Gi/Go family
G protein (identity unknown)
Calcium channel
Other - See Comments
Comments:  Even though data argue strongly for FZD2 signalling via heterotrimeric G proteins, no direct interaction between FZD2 and the G protein has been shown yet. Thus direct proof for G protein-coupling of this receptor is still not available.

WNT-5A/FZD2 binding in F9 cells induced a PTX-sensitive and PDE6-dependent decrease in cGMP and increase in Ca2+ suggesting a very likely involvement of heterotrimeric G proteins [1].
References:  1,6-7
Tissue Distribution Click here for help
Adult heart, fetal brain, lung, kidney.
Species:  Human
Technique:  Northern blotting.
References:  10
Arthritic synovial tissue.
Species:  Human
Technique:  RT-PCR.
References:  12
Fetal brain, lung, kidney, adult heart, skeletal muscle, ovary, testis, pancreas > fetal liver, adult lung, liver, prostate, colon, small intestine > adult brain, placenta, spleen, leukocytes, thymus.
Species:  Human
Technique:  Northern blotting.
References:  19
Brain, eye, heart, kidney, lung, spleen, testis.
Species:  Mouse
Technique:  Northern blotting.
References:  16
Developing mouse thoracic arterial system and heart.
Species:  Mouse
Technique:  Whole mount in situ hybridisation
References:  15
Adult: kidney, liver, uterus, ovary, heart > brain, small intestine > calvaria, lung, mammary gland, testis.
Species:  Rat
Technique:  Northern blotting.
References:  2
Expression Datasets Click here for help

Show »

Log average relative transcript abundance in mouse tissues measured by qPCR from Regard, J.B., Sato, I.T., and Coughlin, S.R. (2008). Anatomical profiling of G protein-coupled receptor expression. Cell, 135(3): 561-71. [PMID:18984166] [Raw data: website]

There should be a chart of expression data here, you may need to enable JavaScript!
Functional Assays Click here for help
Measurement of cGMP levels in mouse F9 teratocarcinoma cells expressing the rat FZD2 receptor.
Species:  Rat
Tissue:  Mouse F9 cells.
Response measured:  WNT-5A conditioned medium-induced decrease in cGMP levels.
References:  1
Measurement of intracellular Ca2+ levels, NFAT-reporter activity and PKG activity via Gt2 and Go in mouse F9 teratocarcinoma cells expressing the rat FZD2 receptor.
Species:  Rat
Tissue:  Mouse F9 cells.
Response measured:  WNT-5A-induced and PTX-sensitive increase in Ca2+ mobilisation, NFAT-reporter activity and PKG activity.
References:  6
Measurement of ATF-2 phosphorylation, p38 kinase activity and phosphorylation, PKG activity and cGMP levels, intracellular Ca2+ mobilisation and PDE activity in mouse F9 cells and HEK 293 cells expressing the rat FXD2 receptor.
Species:  Rat
Tissue:  Mouse F9 cells, HEK 293 cells.
Response measured:  WNT-5A-induced, PTX-sensitive increase in ATF-2 phosphorylation, p38 activity/phosphorylation, decrease in PKG activity and cGMP levels, mobilisation of Ca2+ and increase in PDE activity.
References:  7
Physiological Consequences of Altering Gene Expression Click here for help
FZD2 receptor knockout mice are viable and normal.
Species:  Mouse
Tissue: 
Technique:  Transgenesis.
References:  14
∼50% of Fz2–/– mice had a cleft palate and died as neonates, and the ∼50% that survived exhibited a variable degree of runting that developed during the early postnatal period
Species:  Mouse
Tissue:  Brain
Technique:  Gene knockouts
References:  18
Phenotypes, Alleles and Disease Models Click here for help Mouse data from MGI

Show »

Allele Composition & genetic background Accession Phenotype Id Phenotype Reference
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0002622 abnormal cochlear hair cell morphology PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0002622 abnormal cochlear hair cell morphology PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0004406 abnormal cochlear hair cell number PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0004406 abnormal cochlear hair cell number PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000266 abnormal heart morphology PMID: 20940229 
Fzd1tm1.1Nat|Fzd2+|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000266 abnormal heart morphology PMID: 20940229 
Fzd1+|Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1+,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000266 abnormal heart morphology PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000452 abnormal mouth morphology PMID: 20940229 
Fzd2tm1.1Nat Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1888513  MP:0002272 abnormal nervous system electrophysiology PMID: 20940229 
Fzd2tm1.1Nat Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1888513  MP:0001983 abnormal olfactory system physiology PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0004491 abnormal orientation of outer hair cell stereociliary bundles PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0004491 abnormal orientation of outer hair cell stereociliary bundles PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0009653 abnormal palate development PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000111 cleft palate PMID: 20940229 
Fzd1tm1.1Nat|Fzd2+|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000111 cleft palate PMID: 20940229 
Fzd2tm1.1Nat Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1888513  MP:0000111 cleft palate PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0000111 cleft palate PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0001575 cyanosis PMID: 20940229 
Fzd2tm1.1Nat Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1888513  MP:0001265 decreased body size PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000284 double outlet heart right ventricle PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0009886 failure of palatal shelf elevation PMID: 20940229 
Fzd2tm1.1Nat Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1888513  MP:0002058 neonatal lethality PMID: 20940229 
Fzd1+|Fzd1tm1.1Nat|Fzd2+|Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd1tm1.1Nat/Fzd1+,Fzd2tm1.1Nat/Fzd2+,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1196625  MGI:1888513  MGI:2135272  MP:0000929 open neural tube PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0000929 open neural tube PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000273 overriding aorta PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0009888 palatal shelves fail to meet at midline PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0000088 short mandible PMID: 20940229 
Fzd1tm1.1Nat|Fzd2tm1.1Nat Fzd1tm1.1Nat/Fzd1tm1.1Nat,Fzd2tm1.1Nat/Fzd2tm1.1Nat
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
MGI:1196625  MGI:1888513  MP:0010402 ventricular septal defect PMID: 20940229 
Fzd1+|Fzd1tm1.1Nat|Fzd2+|Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd1tm1.1Nat/Fzd1+,Fzd2tm1.1Nat/Fzd2+,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1196625  MGI:1888513  MGI:2135272  MP:0010402 ventricular septal defect PMID: 20940229 
Fzd2tm1.1Nat|Vangl2+|Vangl2Lp Fzd2tm1.1Nat/Fzd2tm1.1Nat,Vangl2Lp/Vangl2+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * LPT/LeJ
MGI:1888513  MGI:2135272  MP:0010402 ventricular septal defect PMID: 20940229 
General Comments
The WNTs that are available in purified and active form for a pharmacological characterisation to date are WNT-3A and WNT-5A [11,17].

FZD2 (mouse) shows high homology to FZD10 (mouse). Since these receptors are encoded by two genes on different chromosomes, they should be seen as two receptor subtypes.

References

Show »

1. Ahumada A, Slusarski DC, Liu X, Moon RT, Malbon CC, Wang HY. (2002) Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP. Science, 298 (5600): 2006-10. [PMID:12471263]

2. Chan SD, Karpf DB, Fowlkes ME, Hooks M, Bradley MS, Vuong V, Bambino T, Liu MY, Arnaud CD, Strewler GJ et al.. (1992) Two homologs of the Drosophila polarity gene frizzled (fz) are widely expressed in mammalian tissues. J Biol Chem, 267 (35): 25202-7. [PMID:1334084]

3. Dijksterhuis JP, Petersen J, Schulte G. (2013) WNT/Frizzled signaling: receptor-ligand selectivity with focus on FZD-G protein signaling and its physiological relevance. Br J Pharmacol,. [PMID:24032637]

4. Gurney A, Axelrod F, Bond CJ, Cain J, Chartier C, Donigan L, Fischer M, Chaudhari A, Ji M, Kapoun AM et al.. (2012) Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci USA, 109 (29): 11717-22. [PMID:22753465]

5. Laeremans H, Hackeng TM, van Zandvoort MA, Thijssen VL, Janssen BJ, Ottenheijm HC, Smits JF, Blankesteijn WM. (2011) Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation, 124 (15): 1626-35. [PMID:21931076]

6. Ma L, Wang HY. (2006) Suppression of cyclic GMP-dependent protein kinase is essential to the Wnt/cGMP/Ca2+ pathway. J Biol Chem, 281 (41): 30990-1001. [PMID:16920709]

7. Ma L, Wang HY. (2007) Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca2+ non-canonical pathway. J Biol Chem, 282 (39): 28980-90. [PMID:17684012]

8. Malik TH, Shivdasani RA. (2000) Structure and expression of a novel frizzled gene isolated from the developing mouse gut. Biochem J, 349 Pt 3: 829-34. [PMID:10903145]

9. Moyes KW, Sip CG, Obenza W, Yang E, Horst C, Welikson RE, Hauschka SD, Folch A, Laflamme MA. (2013) Human embryonic stem cell-derived cardiomyocytes migrate in response to gradients of fibronectin and Wnt5a. Stem Cells Dev, 22 (16): 2315-25. [PMID:23517131]

10. Sagara N, Toda G, Hirai M, Terada M, Katoh M. (1998) Molecular cloning, differential expression, and chromosomal localization of human frizzled-1, frizzled-2, and frizzled-7. Biochem Biophys Res Commun, 252 (1): 117-22. [PMID:9813155]

11. Schulte G, Bryja V, Rawal N, Castelo-Branco G, Sousa KM, Arenas E. (2005) Purified Wnt-5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation. J Neurochem, 92 (6): 1550-3. [PMID:15748172]

12. Sen M, Lauterbach K, El-Gabalawy H, Firestein GS, Corr M, Carson DA. (2000) Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci USA, 97 (6): 2791-6. [PMID:10688908]

13. Uitterdijk A, Hermans KC, de Wijs-Meijler DP, Daskalopoulos EP, Reiss IK, Duncker DJ, Matthijs Blankesteijn W, Merkus D. (2016) UM206, a selective Frizzled antagonist, attenuates adverse remodeling after myocardial infarction in swine. Lab Invest, 96 (2): 168-76. [PMID:26658451]

14. van Amerongen R, Berns A. (2006) Knockout mouse models to study Wnt signal transduction. Trends Genet, 22 (12): 678-89. [PMID:17045694]

15. van Gijn ME, Blankesteijn WM, Smits JF, Hierck B, Gittenberger-de Groot AC. (2001) Frizzled 2 is transiently expressed in neural crest-containing areas during development of the heart and great arteries in the mouse. Anat Embryol, 203 (3): 185-92. [PMID:11303904]

16. Wang Y, Macke JP, Abella BS, Andreasson K, Worley P, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J. (1996) A large family of putative transmembrane receptors homologous to the product of the Drosophila tissue polarity gene frizzled. J Biol Chem, 271 (8): 4468-76. [PMID:8626800]

17. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates 3rd JR, Nusse R. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature, 423 (6938): 448-52. [PMID:12717451]

18. Yu H, Smallwood PM, Wang Y, Vidaltamayo R, Reed R, Nathans J. (2010) Frizzled 1 and frizzled 2 genes function in palate, ventricular septum and neural tube closure: general implications for tissue fusion processes. Development, 137 (21): 3707-17. [PMID:20940229]

19. Zhao Z, Lee CC, Baldini A, Caskey CT. (1995) A human homologue of the Drosophila polarity gene frizzled has been identified and mapped to 17q21.1. Genomics, 27 (2): 370-3. [PMID:7558010]

Contributors

Show »

How to cite this page